Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage
This study is ongoing, but not recruiting participants.
Study NCT00606905   Information provided by University of Chicago
First Received: January 23, 2008   Last Updated: July 25, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Miscarriage, Recurrent
Abortion, Habitual
Additional conditions recognized in this trial
Abortion, Spontaneous
Recurrence
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Pregnancy Complications
Interventions listed in this trial
Gamimune N or Gamunex 10%
normal saline
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Chicago
University of British Columbia
University of Tennessee
Sunnybrook Health Sciences Centre
Talecris Biotherapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services